(Q45012560)

8 December 2017

Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines (English)

1 reference

8 December 2017

0 references

H S Pall

1

1 reference

8 December 2017

A C Williams

series ordinal

2

1 reference

8 December 2017

D R Blake

series ordinal

3

1 reference

8 December 2017

J Lunec

series ordinal

4

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 September 1987

1 reference

8 December 2017

1 reference

8 December 2017

2

1 reference

8 December 2017

596-599

1 reference

8 December 2017

8559

1 reference

A survey of drug-induced extrapyramidal reactions

8 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

Drug-induced parkinsonism in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

Tardive dyskinesia: summary of a Task Force Report of the American Psychiatric Association. By the Task Force on Late Neurological Effects of Antipsychotic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

Neuropathological investigation of 28 brains from patients with dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

The long-term effect of perphenazine enanthate on the rat brain. Some metabolic and anatomical observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

Evidence for cell loss in corpus striatum after long-term treatment with a neuroleptic drug (flupenthixol) in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

Interaction of trace metals with phenothiazine drug derivatives. I. Structure-reactivity correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

The distribution of copper in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

Free-radical oxidation and antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

Copper-phenanthroline-induced site-specific oxygen-radical damage to DNA. Detection of loosely bound trace copper in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

Raised cerebrospinal-fluid copper concentration in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

Age pigments and free radicals: fluorescent lipid complexes formed by iron- and copper-containing proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

LIPID PEROXIDATION AND PARKINSON'S DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

Effect of chlorphromazine on central nervous system concentrations of manganese, iron, and copper

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

Effect of iron chelators on dopamine D2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

Low serum iron status and akathisia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

COPPER CHELATION AND THE NEURO-OPHTHALMIC TOXICITY OF DESFERRIOXAMINE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

Alpha-tocopherol in tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992987-4

7 January 2021

10.1016/S0140-6736(87)92987-4

Identifiers

DOI

1 reference

8 December 2017

1 reference